# US Fertility Services Market

> US Fertility Services Market Research Report: Size, Share, Trend Analysis By Underlying Cause (Male Infertility, Female Infertility) and By Treatment Type (ART, Infertility Drugs)-Competitor Industry Analysis and Trends Forecast Till 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 10.93%
- **2024:** $ 11.5 Billion
- **2025:** $ 12.76 Billion
- **2035:** $ 36 Billion
- **Key Players:** IVF Australia (AU), Fertility Centers of Illinois (US), CCRM Fertility (US), New Hope Fertility Center (US), Reproductive Health Specialists (US), Boston IVF (US), The Fertility Institute (US), Create Fertility (GB)

**Report ID:** MRFR/HS/14196-HCR · **Pages:** 200 · **Author:** Rahul Gotadki · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/us-fertility-services-market-15723

---

## Market Summary

## **US Fertility Services Market Overview**

The US Fertility Services Market Industry is expected to grow from 10.54(USD Billion) in 2024 to 30.19 (USD Billion) by 2035. The US Fertility Services Market CAGR (growth rate) is expected to be around 10.044% during the forecast period (2025-2035).

### **Key US Fertility Services Market Trends Highlighted**

Numerous reasons have contributed to the notable expansion of the US fertility services industry. The public's growing understanding and acceptance of assisted reproductive technology has proven crucial. Fertility treatments are becoming more attractive due to increased success rates brought about by advancements in medical technology and procedures like in vitro fertilization (IVF) and genetic testing. Additionally, more people are seeking fertility services as a result of the growing tendency of postponed motherhood brought on by lifestyle and job choices.

Another issue is the expansion of fertility clinics around the United States, which makes them more accessible to a wider range of people. There are several opportunities in the US market for fertility services. The potential expansion of telemedicine services, which enable patients to obtain consultations and follow-ups remotely, is one noteworthy topic. Access to reproductive treatments may become easier as a result, especially for people who live in remote places or have mobility issues. Collaborations between technology companies and reproductive clinics can result in creative solutions that optimize services, improving patient care and treatment procedures.

Personalized treatment plans have been increasingly popular in recent years, with clinics concentrating on customizing solutions based on each patient's unique genetic and health information. Additionally, as more women want to preserve their fertility for later use, egg-freezing services are becoming more and more popular. More people are talking about infertility and embracing social acceptability, which promotes conversations that further de-stigmatize asking for help. A surge in service use might result from this greater openness, suggesting favorable market dynamics in the US fertility services industry.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

## **US Fertility Services Market Drivers**

### **Rising Infertility Rates**

The US Fertility Services Market Industry is experiencing significant growth, driven in large part by the rising infertility rates among couples. According to the Centers for Disease Control and Prevention (CDC), one in eight couples of reproductive age in the United States faces difficulty getting pregnant or carrying a pregnancy to term. Factors contributing to this increase include delayed childbearing, lifestyle factors such as obesity, and environmental influences. With more couples seeking effective solutions, demand for fertility services has surged.

The American Society for Reproductive Medicine has noted a 7% annual increase in assisted reproductive technologies (ART) procedures conducted in the country, indicating a robust market. The rising awareness and acceptance of fertility treatments among the population contribute to the expanded growth prospects in the US Fertility Services Market.

### **Technological Advances in Fertility Treatment**

Technological innovation is a key driver in the US Fertility Services Market Industry. Recent developments, such as the refinement of in vitro fertilization (IVF) techniques and the introduction of preimplantation genetic testing (PGT), have significantly increased success rates in fertility treatments. The Society for Assisted Reproductive Technology reports that IVF success rates have nearly doubled over the last decade, now typically reaching around 40% for women under age 35. As women become more informed about their reproductive options and the effectiveness of these technologies, there is an increase in demand for advanced fertility solutions.

This wave of innovation, supported by contributions from organizations such as the Center for Disease Control and the American Society for Reproductive Medicine, is galvanizing growth in the market.

### **Increased Insurance Coverage for Fertility Treatments**

Increasing insurance coverage for fertility services is another important driver in the US Fertility Services Market Industry. Many states are implementing mandates that require insurance plans to offer coverage for infertility treatment. According to the National Conference of State Legislatures, as of 2021, 19 states have laws requiring insurers to cover fertility treatments, which directly impacts accessibility and affordability. This shift has enhanced the willingness of individuals and couples to pursue fertility treatments, reducing out-of-pocket costs and thereby increasing treatment uptake.

Organizations like Resolve: The National Infertility Association advocate for broader insurance coverage, which plays a crucial role in influencing policy and insurance guidelines, thus boosting the US Fertility Services Market.

## **US Fertility Services Market Segment Insights**

### **Fertility Services Market Underlying Cause Insights  **

The US Fertility Services Market demonstrates a robust potential for growth, particularly in the Underlying Cause segment, where the focus encompasses critical aspects of male and female infertility. This segmentation highlights the increasing awareness and diagnosis of infertility issues among couples, driving the demand for effective fertility treatment solutions. Male infertility is often linked to factors such as low sperm count and motility, which have gained attention in recent years due to lifestyle changes and environmental influences.

The significance of this issue cannot be understated, as a substantial percentage of infertility cases are attributed to male-related factors, leading to a demand for specialized treatments and tests tailored to address these concerns. On the other hand, female infertility remains a major challenge, with age-related factors playing a crucial role in a woman’s ability to conceive, as fertility tends to decline significantly as women age. Conditions such as polycystic ovary syndrome (PCOS) and endometriosis further complicate female reproductive health, necessitating advanced medical interventions.

Consequently, the US Fertility Services Market data indicates a growing investment in research and innovative treatment options aimed at tackling both male and female infertility effectively. These developments are encouraging not only from a medical perspective but also in terms of emotional support for couples experiencing difficulty in conceiving. Overall, the focus on the Underlying Cause segment reflects the changing landscape of reproductive health in the US, as healthcare providers increasingly recognize the need for comprehensive fertility evaluations that encompass both partners.

The rising trend of specialist clinics and personalized treatment plans caters to the nuanced needs of individuals facing fertility challenges. Government initiatives supporting reproductive health awareness further bolster growth within this segment, aligning with broader healthcare objectives aimed at improving family planning outcomes across the nation. The US Fertility Services Market segmentation thus plays a pivotal role in understanding the underlying causes of infertility, paving the way for innovative solutions and improved patient care that resonate with couples navigating the complexities of reproductive health.

**Source: Primary Research, Secondary Research, MRFR Database and Analyst Review**

### **Fertility Services Market Treatment Type Insights  **

The Treatment Type segment of the US [Fertility Services Market](../../../reports/fertility-services-market-6281) comprises various methodologies crucial for addressing infertility challenges. Among these, Assisted Reproductive Technology (ART) has garnered significant attention for its effectiveness in pairing with technological advancements, leading to higher success rates in achieving pregnancies. This method often comprises procedures such as in vitro fertilization (IVF), which remains a widely recognized solution for couples facing fertility issues. On the other hand, infertility drugs play a vital role in stimulating ovulation and enhancing fertility outcomes, making them a preferred choice for many seeking less invasive options.

The increasing awareness about fertility treatments and the rising infertility rates in the US are driving this segment's growth. Additionally, factors such as later-in-life pregnancies and lifestyle-related infertility are contributing to the higher demand for these treatments. As the landscape evolves, innovations in ART technologies and drug formulations are anticipated to further enhance treatment efficacy, thereby expanding options for individuals and increasing US Fertility Services Market revenue in the coming years. These dynamics highlight the essential role both ART and infertility drugs hold in the market's overall success and growth.

## **US Fertility Services Market Key Players and Competitive Insights**

The US Fertility Services Market is experiencing significant growth driven by increasing infertility rates, heightened awareness of reproductive health, and advancements in assisted reproductive technologies. The market is characterized by a mix of established healthcare providers and new entrants, focusing on innovative treatments and comprehensive fertility solutions. Competition within this space is intensified by growing consumer demand for personalized care, along with a shift towards transparency in pricing and service offerings. As such, industry players are actively seeking to differentiate their services, enhance patient experiences, and forge partnerships with healthcare systems to expand their reach and capabilities.

The landscape is further complicated by the involvement of insurance companies and government policies that shape accessibility and affordability, making it critical for stakeholders to remain agile and adaptive to evolving market dynamics. UnitedHealth Group stands out in the US Fertility Services Market by leveraging its extensive insurance network and integrated health services model. The company's strengths lie in its ability to provide a comprehensive suite of services, which not only includes fertility treatments but also access to diagnostic testing and counseling services.

This holistic approach enables UnitedHealth Group to support patients throughout their fertility journey, thereby improving outcomes and satisfaction. Its large-scale operations allow for economies of scale, enhancing efficiency and reducing costs. Moreover, the company has made significant investments in technology and digital health solutions, facilitating better patient engagement and streamlined service delivery. As a trusted partner in fertility care, UnitedHealth Group continues to expand its market presence, ensuring that it meets the evolving needs of consumers effectively.

Cerner Corporation plays a pivotal role in the US Fertility Services Market by providing advanced health information technology solutions that support fertility clinics and healthcare providers. The company’s key products focus on electronic health records and data management systems specifically designed for reproductive health. Cerner's strength lies in its ability to streamline clinic operations, enhance patient data accessibility, and enable better decision-making through analytics and reporting tools. The company has a strategic focus on partnerships with fertility centers, which aids in improving the integration of care delivery and optimizing clinic performance.

Cerner Corporation also engages in mergers and acquisitions to enhance its service offerings, allowing it to incorporate new technologies that meet the unique needs of the fertility sector. With a prominent market presence bolstered by its innovative solutions, Cerner continues to be a vital player in shaping the landscape of fertility services in the United States.

### **Key Companies in the US Fertility Services Market Include**

## **US Fertility Services Market Industry Developments**

The US Fertility Services Market has been witnessing significant developments recently, primarily driven by advancements in technology and increased awareness regarding fertility treatments. Companies like UnitedHealth Group and Cerner Corporation have been expanding their services to integrate more comprehensive reproductive health solutions. Notably, in September 2023, the Fertility and IVF Centers of America announced a strategic partnership with Prelude Fertility to enhance patient access to IVF services across the nation. The growing market valuation of companies such as Shady Grove Fertility and CCRM Fertility reflects an upward trend, resulting in increased investments aimed at service expansion and technological innovation.

The impact of the COVID-19 pandemic has also led to a rebound in demand for fertility services, with Boston IVF and New Hope Fertility Center reporting higher patient volumes in 2023 compared to previous years. Additionally, the Fertility Specialists of Texas and Vios Fertility Institute have been at the forefront of adopting telehealth services to offer consultations and follow-ups, facilitating greater patient engagement. Overall, the market continues to evolve rapidly with a focus on accessibility and advanced treatment options, supported by substantial investments and partnerships within the sector.

## **Fertility Services Market Segmentation Insights**

### **Fertility Services Market Underlying Cause Outlook**

- Male Infertility
- Female Infertility

### **Fertility Services Market Treatment Type Outlook**

- ART
- Infertility Drugs

## Market Drivers

### Changing Societal Norms

Changing societal norms regarding family planning and childbearing are influencing the fertility services market. As more individuals prioritize career and personal development before starting families, the average age of first-time parents has increased significantly over the past few decades.. This shift often leads to a higher incidence of infertility, prompting a greater need for fertility services. Additionally, acceptance of assisted reproductive technologies has grown, with many viewing these services as viable options rather than last resorts. This evolving perspective is likely to sustain demand for fertility services, indicating a robust market trajectory.

### Rising Infertility Rates

The fertility services market is experiencing growth due to rising infertility rates among couples in the US. Factors such as delayed childbearing, lifestyle choices, and environmental influences contribute to this trend. According to the CDC, approximately 12% of women aged 15-44 face difficulties in conceiving, which drives demand for fertility services. As awareness of infertility issues increases, more individuals seek assistance, leading to a greater reliance on reproductive technologies. This trend suggests that the fertility services market will continue to expand as more couples turn to medical interventions to achieve their family planning goals.

### Increased Public Awareness

Public awareness regarding fertility issues is on the rise, significantly influencing the fertility services market. Educational campaigns and social media discussions have shed light on infertility, encouraging individuals to seek help sooner. As more people understand the available options, including IVF and egg freezing, the demand for these services is likely to increase. Reports suggest that around 30% of women are now aware of fertility preservation techniques, which could lead to a surge in consultations and treatments. This heightened awareness is expected to drive growth in the fertility services market.

### Insurance Coverage Expansion

The fertility services market is positively impacted by the expansion of insurance coverage for fertility treatments. Many states in the US have enacted laws requiring insurance companies to provide coverage for infertility diagnosis and treatment. This legislative support has made fertility services more accessible to a broader demographic, potentially increasing the market size. As of 2025, approximately 15 states mandate some level of fertility treatment coverage, which encourages couples to pursue necessary medical interventions without the burden of high out-of-pocket costs. This trend indicates a growing recognition of fertility services as essential healthcare.

### Advancements in Reproductive Technology

The fertility services market is benefiting from advancements in reproductive technology, which enhance treatment success rates. Innovations such as preimplantation genetic testing (PGT) and improved cryopreservation techniques have revolutionized the field. These technologies not only increase the likelihood of successful pregnancies but also provide patients with more options tailored to their specific needs. As success rates improve, more couples are likely to consider fertility treatments, thereby expanding the market. The ongoing research and development in this area suggest a promising future for the fertility services market.

## Future Outlook

The [Fertility Services Market](https://www.marketresearchfuture.com/reports/fertility-services-market-6281) is projected to grow at a 10.93% CAGR from 2025 to 2035, driven by technological advancements, increasing infertility rates, and rising awareness.

**New opportunities:**

- Expansion of telehealth services for remote consultations
- 
- Development of personalized fertility treatment plans
- Investment in AI-driven diagnostic tools for enhanced patient outcomes

By 2035, the market is expected to achieve substantial growth, reflecting evolving consumer needs and technological innovations.

## Segment Insights

### By Treatment Type: In Vitro Fertilization (Largest) vs. Intracytoplasmic Sperm Injection (Fastest-Growing)

In the US fertility services market, In Vitro Fertilization (IVF) holds the largest market share among various treatment types, significantly contributing to the industry's overall growth. Following IVF, Intracytoplasmic Sperm Injection (ICSI) and Artificial Insemination also occupy important positions, yet their shares are smaller compared to IVF. The rising acceptance of assisted reproductive technologies is propelling these treatment types into greater prominence, particularly among couples facing infertility challenges.

Growth trends in the market are largely driven by advancements in reproductive technologies and increasing awareness regarding infertility treatments. The evolution of patient-centric methods and the success rates associated with IVF and ICSI have further enhanced their popularity. Furthermore, improving healthcare policies and the rising prevalence of lifestyle-related infertility issues have generated a greater demand for these services, with ICSI emerging as the fastest-growing treatment option due to its effectiveness in cases of male infertility.

In Vitro Fertilization (Dominant) vs. Intracytoplasmic Sperm Injection (Emerging)

In Vitro Fertilization (IVF) is the dominant treatment type in the US fertility services market, known for its robust success rates and the ability to address various infertility issues. Many clinics offer comprehensive IVF packages, integrating counseling and support services to enhance patient experience. On the other hand, Intracytoplasmic Sperm Injection (ICSI) is an emerging treatment that has gained traction due to its specialized approach for male infertility. ICSI involves injecting a single sperm directly into an egg, which can significantly increase the chances of successful fertilization. As technology continues to advance, both IVF and ICSI will play critical roles in shaping the future of reproductive health services.

### By Patient Type: Female Infertility (Largest) vs. Male Infertility (Fastest-Growing)

In the US fertility services market, the patient type segment is significantly dominated by female infertility, which constitutes the largest share of the market. Female infertility services are widely sought after due to various underlying health issues, including age-related factors and medical conditions. This segment is followed by male infertility, which is garnering increasing attention due to changing societal norms and awareness about male reproductive health. Couples with unexplained infertility also maintain a substantial presence, reflecting the complexities of fertility challenges faced by many.

The growth trends within this segment are notable, particularly for male infertility services, which is emerging as the fastest-growing area in the market. Factors driving this growth include increasing awareness, improved diagnostic options, and societal acceptance of male infertility treatments. Additionally, same-sex couples and single parents are also contributing to the diversification of services offered, as more individuals seek tailored fertility solutions. The collective rise in demand indicates a shift towards more inclusive approaches in the fertility services landscape.

Female Infertility: Dominant vs. Male Infertility: Emerging

Female infertility is characterized by a wide range of causes, including ovulatory disorders, uterine abnormalities, and advanced maternal age, making it the dominant force in the US fertility services market. It is supported by extensive resources, education, and a variety of treatment options including IVF, medication, and surgical interventions. Meanwhile, male infertility is emerging rapidly due to increased awareness and advocacy surrounding men’s health issues. More men are seeking help, which is shifting perceptions and leading to innovative treatments. The growth of male infertility treatment options has been further fueled by advancements in reproductive technologies and a growing recognition of male factors in infertility cases, making it a crucial area in the evolving fertility landscape.

### By End User: Fertility Clinics (Largest) vs. Hospitals (Fastest-Growing)

In the US fertility services market, Fertility Clinics hold a significant portion of the market share, establishing themselves as the most preferred destination for assisted reproductive technologies. Hospitals also contribute notably, but they face competition from specialized fertility clinics that offer tailored treatments and a more personalized approach. The market dynamics indicate a preference for clinics due to their focused services, ultimately shaping the market landscape.

Growth trends within this segment are driven by increasing awareness regarding fertility issues and advancements in reproductive technologies. Fertility Clinics are benefitting from a surge in demand for personalized care, while Hospitals are seeing growth due to their integrated health services. Moreover, insurance coverage expansions for fertility treatments in some states are further fueling market growth, leading both segments to adapt and innovate.

Fertility Clinics (Dominant) vs. Hospitals (Emerging)

Fertility Clinics are at the forefront of the US fertility services market, offering specialized treatment options such as IVF, ICSI, and egg donation services. They are characterized by their dedicated personnel and state-of-the-art laboratory facilities that enhance patient outcomes. The patient-centric approach and flexible scheduling options contribute to their dominant position. In contrast, Hospitals are emerging players in this segment, leveraging their comprehensive health services to integrate fertility care within a broader medical framework. Their growth is marked by investments in fertility units and collaborations with fertility specialists, although they still face challenges in delivering the same level of specialization as Fertility Clinics.

### By Service Type: Consultation Services (Largest) vs. Treatment Services (Fastest-Growing)

The US fertility services market shows a diverse distribution of market share among its service types. Consultation services hold the largest share, being the first point of contact for individuals seeking fertility assistance. Following closely are diagnostic services, which are essential for determining fertility issues before treatment begins. Treatment services, while currently smaller in share, have seen a notable increase in engagements due to advancements in technology and wider accessibility of procedures.

Growth trends within the US fertility services market are heavily influenced by societal factors such as rising infertility rates and increased awareness of reproductive health. Additionally, the adoption of innovative treatment methods and enhanced diagnostic capabilities are driving the demand for treatment services. As clinics expand their offerings and marketing efforts, treatment services are projected to grow rapidly, establishing themselves as a critical component of the overall market landscape.

Consultation Services (Dominant) vs. Treatment Services (Emerging)

Consultation services are characterized by their role as the foundational entry point for patients exploring fertility options, providing essential guidance and support throughout the process. They dominate the market due to the necessity of initial assessments and personalized care plans for couples facing infertility challenges. On the other hand, treatment services are emerging as a crucial segment, reflecting the growing demand for advanced reproductive technologies such as in vitro fertilization (IVF) and hormonal therapies. These services are rapidly gaining traction, driven by technological innovations, increasing public awareness, and more accessible financing options, which together enhance their appeal and adoption among prospective parents.

## Competitive Benchmarking

The fertility services market in the US is characterized by a dynamic competitive landscape, driven by increasing demand for assisted reproductive technologies (ART) and a growing awareness of fertility issues. Key players such as Fertility Centers of Illinois (US), CCRM Fertility (US), and Boston IVF (US) are strategically positioned to leverage innovation and expand their service offerings. Fertility Centers of Illinois (US) focuses on patient-centered care and has recently enhanced its telehealth services, which appears to cater to the rising preference for remote consultations. CCRM Fertility (US) emphasizes cutting-edge technology and has invested in advanced genetic testing, which may enhance success rates and attract a broader patient base. Boston IVF (US) is known for its comprehensive approach, integrating wellness programs with ART, which suggests a holistic strategy to improve patient outcomes and satisfaction.The business tactics employed by these companies reflect a moderately fragmented market structure, where local players compete alongside larger institutions. Key tactics include optimizing supply chains and localizing services to meet regional demands. This competitive structure allows for a diverse range of offerings, enabling companies to differentiate themselves through specialized services and innovative technologies.
In October CCRM Fertility (US) announced a partnership with a leading biotechnology firm to develop a new AI-driven platform for personalized treatment plans. This strategic move is likely to enhance patient outcomes by tailoring interventions based on individual genetic profiles, thereby positioning CCRM as a leader in precision medicine within the fertility sector. The integration of AI into treatment protocols may also streamline operations and reduce costs, further solidifying their competitive edge.
In September Boston IVF (US) launched a new initiative aimed at increasing access to fertility treatments for underserved populations. This initiative, which includes financial assistance programs and community outreach, underscores Boston IVF's commitment to social responsibility and may enhance its reputation while expanding its market reach. By addressing disparities in access, the company not only fulfills a critical need but also potentially increases its patient base.
In August Fertility Centers of Illinois (US) expanded its telehealth services to include virtual support groups for patients undergoing fertility treatments. This strategic enhancement reflects a growing trend towards digitalization in healthcare, allowing for greater patient engagement and support. By fostering a community among patients, the center may improve retention rates and overall satisfaction, which are crucial in a competitive market.
As of November the competitive trends in the fertility services market are increasingly defined by digital transformation, sustainability initiatives, and the integration of AI technologies. Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in enhancing service offerings and operational efficiencies. Looking ahead, competitive differentiation is likely to evolve from traditional price-based strategies to a focus on innovation, technological advancements, and reliable supply chains. This shift may redefine success in the market, emphasizing the importance of quality and patient experience over cost alone.

## Recent News & Developments

The US Fertility Services Market has been witnessing significant developments recently, primarily driven by advancements in technology and increased awareness regarding fertility treatments. Companies like UnitedHealth Group and Cerner Corporation have been expanding their services to integrate more comprehensive reproductive health solutions. Notably, in September 2023, the Fertility and IVF Centers of America announced a strategic partnership with Prelude Fertility to enhance patient access to IVF services across the nation. The growing market valuation of companies such as Shady Grove Fertility and CCRM Fertility reflects an upward trend, resulting in increased investments aimed at service expansion and technological innovation.

The impact of the COVID-19 pandemic has also led to a rebound in demand for fertility services, with Boston IVF and New Hope Fertility Center reporting higher patient volumes in 2023 compared to previous years. Additionally, the Fertility Specialists of Texas and Vios Fertility Institute have been at the forefront of adopting telehealth services to offer consultations and follow-ups, facilitating greater patient engagement. Overall, the market continues to evolve rapidly with a focus on accessibility and advanced treatment options, supported by substantial investments and partnerships within the sector.

## Report Scope

| MARKET SIZE 2024 | 11.5(USD Billion) |
| --- | --- |
| MARKET SIZE 2025 | 12.76(USD Billion) |
| MARKET SIZE 2035 | 36.0(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 10.93% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | IVF Australia (AU), Fertility Centers of Illinois (US), CCRM Fertility (US), New Hope Fertility Center (US), Reproductive Health Specialists (US), Boston IVF (US), The Fertility Institute (US), Create Fertility (GB) |
| Segments Covered | Treatment Type, Patient Type, End User, Service Type |
| Key Market Opportunities | Integration of advanced genetic testing technologies enhances personalized treatment options in the fertility services market. |
| Key Market Dynamics | Technological advancements and shifting consumer preferences drive growth in the fertility services market. |
| Countries Covered | US |

## Frequently Asked Questions

**Q: What is the current valuation of the US fertility services market?**
A: The market valuation was $11.5 Billion in 2024.

**Q: What is the projected market size for the US fertility services market by 2035?**
A: The market is expected to reach $36.0 Billion by 2035.

**Q: What is the expected CAGR for the US fertility services market during the forecast period 2025 - 2035?**
A: The expected CAGR is 10.93% during the forecast period.

**Q: Which treatment type holds the largest market share in the US fertility services market?**
A: In Vitro Fertilization accounted for $4.6 Billion in 2024 and is projected to grow to $14.4 Billion by 2035.

**Q: How does the market for male infertility compare to female infertility in the US?**
A: Female infertility was valued at $4.6 Billion in 2024, while male infertility was valued at $2.3 Billion.

**Q: What are the primary end users of fertility services in the US?**
A: Fertility clinics represented $4.6 Billion in 2024, with hospitals and home care also contributing significantly.

**Q: What role do consultation services play in the US fertility services market?**
A: Consultation services were valued at $2.3 Billion in 2024 and are expected to grow during the forecast period.

**Q: Which key players are leading the US fertility services market?**
A: Key players include IVF Australia, Fertility Centers of Illinois, and CCRM Fertility, among others.

**Q: What is the market size for surrogacy services in the US fertility services market?**
A: Surrogacy services were valued at $2.1 Billion in 2024 and are projected to reach $6.6 Billion by 2035.

**Q: How does the market for same-sex couples compare to single parents in the US fertility services market?**
A: Same-sex couples represented $1.5 Billion in 2024, while single parents accounted for $1.1 Billion.

**Q: What is the projected market size for the US Fertility Services Market by 2035?**
A: By 2035, the US Fertility Services Market is projected to reach a value of 25.0 billion USD.

**Q: What are the key players in the US Fertility Services Market?**
A: Key players in the US Fertility Services Market include Merck and Co, Texas Fertility Center, and Boston IVF among others.

**Q: What is the market value for male infertility services in 2024?**
A: The market value for male infertility services is expected to be 3.42 billion USD in 2024.

**Q: What will be the market value for female infertility services by 2035?**
A: By 2035, the market value for female infertility services is anticipated to reach 16.75 billion USD.

**Q: What are the growth drivers for the US Fertility Services Market?**
A: The growth drivers for the US Fertility Services Market include increasing awareness and advancements in fertility technologies.

**Q: Which segment is expected to witness the highest growth in the US Fertility Services Market by 2035?**
A: The female infertility segment is expected to witness significant growth, reaching 16.75 billion USD by 2035.

**Q: How does the market for fertility services compare between male and female infertility in 2024?**
A: In 2024, the market for female infertility services is valued at 7.12 billion USD, compared to 3.42 billion USD for male infertility services.

**Q: What challenges could impact the growth of the US Fertility Services Market?**
A: Challenges that could impact growth include regulatory hurdles and high treatment costs affecting accessibility.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-fertility-services-market-15723*